FWP
AZN icon

FAS Wealth Partners’s AstraZeneca AZN Stock Holding History

FAS Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Sell
1,390
-77
-5% -$14.8K 0.02% 301
2025
Q4 		$270K Buy
1,467
+100
+7% +$17.5K 0.02% 299
2025
Q3 		$210K Buy
+1,367
New +$207K 0.01% 308
2024
Q4 		– Sell
-1,332
Closed -$208K – 431
2024
Q3 		$208K Buy
1,332
+7
+0.5% +$1.13K 0.02% 296
2024
Q2 		$207K Buy
+1,325
New +$199K 0.02% 286
2023
Q2 		– Sell
-3,209
Closed -$445K – 413
2023
Q1 		$445K Sell
3,209
-24
-0.7% -$3.23K 0.05% 204
2022
Q4 		$438K Buy
3,233
+38
+1% +$4.76K 0.05% 208
2022
Q3 		$350K Buy
3,195
+8
+0.3% +$1.01K 0.04% 212
2022
Q2 		$421K Hold
3,187
– – 0.04% 198
2022
Q1 		$423K Buy
3,187
+14
+0.4% +$1.68K 0.04% 202
2021
Q4 		$370K Buy
3,173
+227
+8% +$26.7K 0.03% 226
2021
Q3 		$354K Buy
2,946
+215
+8% +$25K 0.03% 215
2021
Q2 		$327K Hold
2,731
– – 0.03% 224
2021
Q1 		$272K Buy
2,731
+6
+0.2% +$603 0.03% 227
2020
Q4 		$272K Buy
2,725
+190
+7% +$20.1K 0.03% 219
2020
Q3 		$278K Buy
2,535
+2
+0.1% +$222 0.04% 206
2020
Q2 		$268K Hold
2,533
– – 0.04% 201
2020
Q1 		$226K Buy
2,533
+7
+0.3% +$659 0.04% 197
2019
Q4 		$252K Hold
2,526
– – 0.04% 177
2019
Q3 		$225K Buy
+2,526
New +$219K 0.04% 184

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

FAS Wealth Partners's AZN Position: Q1 2026 in Review

FAS Wealth Partners reduced its AstraZeneca (AZN) stake by 5.2% in Q1 2026, selling an estimated $14.8K and leaving 1,390 shares worth $274K. The position accounts for 0.02% of the portfolio, ranked #301.

FAS Wealth Partners first reported a position in AZN in Q3 2019 and has held it in 20 quarters since. The position peaked at $445K in Q1 2023. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • FAS Wealth Partners held 1,390 shares of AstraZeneca worth $274K as of Q1 2026.
  • FAS Wealth Partners sold 77 AstraZeneca shares in Q1 2026, an estimated $14.8K.
  • AstraZeneca made up 0.02% of FAS Wealth Partners's portfolio in Q1 2026, its #301 holding.
  • FAS Wealth Partners first reported a position in AstraZeneca in Q3 2019 and has held it in 20 quarters since.
  • FAS Wealth Partners's AstraZeneca position peaked at $445K in Q1 2023.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on FAS Wealth Partners's 13F filing for Q1 2026, filed 10 Jun 2026.